-
Dr. Bruce C. Hemming President & CEO
Dr. Hemming is an accomplished science and business professional with over 30 years of real-world experience in microbiology and its practical applications. In 1982 he received his doctorate in Plant Pathology from Montana State University – Bozeman. His BS degree in Microbiology and MS degree in Biochemistry are both from Brigham Young University, Utah. He is the founder and president of Microbe Inotech Laboratories, which is now in its 18th year of business. As an educator, Dr. Hemming served as an adjunct professor at St. Louis University as well as University of Missouri – St. Louis, and as a visiting faculty member for the Institute for Genetics Education at the University of Wisconsin. He currently serves on three biotechnology committees for multi-disciplinary teams involved in original research. He has earned several patents on his research within the field of microbiology. Dr. Hemming was charged with the development of creative exploratory research within crop protection technology with a focus on biological control and microbial genetics and served as Biocontrol Project Leader in the development of bio fungicides in conjunction with CSIRO Division of Solis Australia and Universities in the U.S.A. His responsibility included the development of collaborative agreements, preparation of regulatory documents, microbial physiology and tracking studies, coordination of the natural product/gene discovery effort, and field trials of various projects, which included the first introduction into the environment in the genetically engineered bacteria containing foreign genes.
-
Dr. Michael N. Ndengele COO Microbe Scan LLC. (USA), COO Microbe Scan LTD. (Kenya) – Ph.D. – Microbiologist / Parasitologist II,
Dr. Ndengele is a Parasitologist, Microbiologist, Biochemist and Cell Biologist. Dr. Ndengele has practiced in both Academia and Industry in designing and performing experiments leading a greater knowledge in and understanding of a variety of microbes with a specific interest in malaria utilizing in vivo and in vitro studies to understand gram-negative bacterial infection and malaria pathology. In addition to those studies, Dr. Ndengele has experience in cell cultures of both mammalian and microbial for use in experimentation to gain a better understanding of the effects of novel drugs on living organisms. Dr. Ndengele has had the opportunity to present his finding at multiple Meeting of the American Thoracic Society Conferences, Nitric Oxide Meeting conference, Meeting of the society of Protozoologists Conference, as well as the Meeting of the American Society of Parasitologists Conference, and to publish his finding in peer-reviewed journals JPET, ARS, Shock, JCI, Experimental Parasitology, AJP-Lung, Journal of immunology, Free Radical Biology& Medicine, and The FASEB Journal.
